Keyphrases
Pulmonary Hypertension
100%
Right Ventricular Function
100%
QT Prolongation
100%
QTc Interval
37%
WHO Group
25%
Right Ventricular Hypertrophy
25%
PAH-specific Therapy
25%
Independent Predictors of Mortality
25%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
25%
Hypertension Patients
12%
Magnetic Resonance Imaging
12%
Cardiac Index
12%
Myocytes
12%
Phosphodiesterase Type 5 Inhibitors
12%
Ejection Fraction
12%
Brain Natriuretic Peptide
12%
End-diastolic Volume
12%
Prostanoids
12%
12-lead Electrocardiogram
12%
Endothelin Receptor Antagonist
12%
Kv Channels
12%
Invasive Hemodynamics
12%
Social Security Death Index
12%
RV Function
12%
Rodent Models
12%
Adverse Prognosis
12%
Medicine and Dentistry
Pulmonary Hypertension
100%
Right Ventricular Function
100%
Polycyclic Aromatic Hydrocarbon
37%
QTc Interval
37%
Electrocardiogram
25%
Right Ventricular Hypertrophy
25%
Magnetic Resonance Imaging
12%
Hemodynamic
12%
Phosphodiesterase V Inhibitor
12%
Ejection Fraction
12%
down Regulation
12%
End-Diastolic Volume
12%
Brain Natriuretic Peptide
12%
Prostanoid
12%
Endothelin Receptor Antagonist
12%
Neuroscience
Hypertension
100%
Right Ventricular Hypertrophy
25%
Magnetic Resonance Imaging
12%
Brain Natriuretic Peptide
12%
End-Diastolic Volume
12%
Phosphodiesterase V
12%
Prostanoid
12%
Myocyte
12%
Endothelin Receptor Antagonist
12%
Cardiac Index
12%